Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(108 sites)

United States

University of Alabama Hospital (UAB Hospital), Birmingham, Alabama

Banner MD Anderson Cancer Center, Gilbert, Arizona

City of Hope Comprehensive Cancer Center - Duarte, Duarte, California

University of California Los Angeles (UCLA) - David Geffen School of Medicine, Los Angeles, California

UCHealth Cancer Care - Anschutz Medical Campus - University of Colorado Cancer Center, Aurora, Colorado